IN2014CN01787A - - Google Patents

Download PDF

Info

Publication number
IN2014CN01787A
IN2014CN01787A IN1787CHN2014A IN2014CN01787A IN 2014CN01787 A IN2014CN01787 A IN 2014CN01787A IN 1787CHN2014 A IN1787CHN2014 A IN 1787CHN2014A IN 2014CN01787 A IN2014CN01787 A IN 2014CN01787A
Authority
IN
India
Prior art keywords
lung cancer
individual
small cell
cell lung
non small
Prior art date
Application number
Inventor
Mehan Michael Riel
Alex A E Stewart
Rachel M Ostroff
Stephen Alaric Williams
Edward N Brody
Original Assignee
Somalogic Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Somalogic Inc filed Critical Somalogic Inc
Publication of IN2014CN01787A publication Critical patent/IN2014CN01787A/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57423—Specifically defined cancers of lung
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/60—Complex ways of combining multiple protein biomarkers for diagnosis

Abstract

The present application includes biomarkers methods devices reagents systems and kits tor the detection and diagnosis of non small cell lung cancer and general cancer. In one aspect the application provides biomarkers that can be used alone or in various combinations to diagnose non small cell lung cancer or general cancer. In another aspect methods are provided for diagnosing non small cell lung cancer in an individual where the methods include detecting in a biological sample from an individual at least one biomarker value corresponding to at least one biomarker selected from the group of biomarkers provided in Table 1 wherein the individual is classified as having lung cancer or the likelihood of the individual having lung cancer is determined based on the at least one biomarker value.
IN1787CHN2014 2011-10-24 2011-10-24 IN2014CN01787A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2011/057499 WO2013062515A2 (en) 2011-10-24 2011-10-24 Lung cancer biomarkers and uses thereof

Publications (1)

Publication Number Publication Date
IN2014CN01787A true IN2014CN01787A (en) 2015-05-29

Family

ID=48168748

Family Applications (1)

Application Number Title Priority Date Filing Date
IN1787CHN2014 IN2014CN01787A (en) 2011-10-24 2011-10-24

Country Status (15)

Country Link
EP (1) EP2771692B1 (en)
JP (1) JP5986638B2 (en)
KR (1) KR101921945B1 (en)
CN (2) CN103890586B (en)
AU (1) AU2011378427B8 (en)
BR (1) BR112014006432B8 (en)
CA (3) CA2847188C (en)
ES (1) ES2674318T3 (en)
IL (2) IL231426A (en)
IN (1) IN2014CN01787A (en)
MX (1) MX355416B (en)
NZ (1) NZ621733A (en)
SG (1) SG11201400375SA (en)
WO (1) WO2013062515A2 (en)
ZA (1) ZA201401476B (en)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104777313B (en) 2010-07-09 2017-09-26 私募蛋白质体公司 Lung cancer biomarkers and application thereof
AU2013388864B2 (en) * 2013-05-09 2017-06-08 The Procter & Gamble Company Method and system for assessing health condition
US11098303B2 (en) 2014-07-30 2021-08-24 President And Fellows Of Harvard College Systems and methods for determining nucleic acids
CN104263723B (en) * 2014-09-15 2017-06-06 南京医科大学 A kind of low frequency related to primary lung cancer auxiliary diagnosis penetrance genetic marker high and its application
WO2016094330A2 (en) * 2014-12-08 2016-06-16 20/20 Genesystems, Inc Methods and machine learning systems for predicting the liklihood or risk of having cancer
JP6857185B2 (en) * 2015-09-11 2021-04-14 アプタマー サイエンス インコーポレイテッドＡｐｔａｍｅｒ Ｓｃｉｅｎｃｅｓ Ｉｎｃ． Protein biomarker panel for non-small cell lung cancer diagnosis and non-small cell lung cancer diagnostic method using this
EP3372686B1 (en) * 2015-11-05 2020-05-20 BGI Shenzhen Biomarker for detection of lung adenocarcinoma and use thereof
KR101853118B1 (en) * 2016-09-02 2018-04-30 주식회사 바이오인프라생명과학 Complex biomarker group for detecting lung cancer in a subject, lung cancer diagnostic kit using the same, method for detecting lung cancer using information on complex biomarker and computing system executing the method
EP3539036A4 (en) * 2016-11-08 2020-06-17 President and Fellows of Harvard College Matrix imprinting and clearing
ES2929392T3 (en) * 2017-03-01 2022-11-28 Hoffmann La Roche Systems, procedure, and computer-readable means for classifying a biological sample with respect to the presence of an analyte
US11788123B2 (en) 2017-05-26 2023-10-17 President And Fellows Of Harvard College Systems and methods for high-throughput image-based screening
CN109116023B (en) * 2018-06-14 2021-06-04 郑州大学第一附属医院 Lung cancer marker anti-MMP 12 autoantibody and application thereof
CN109470859A (en) * 2018-11-04 2019-03-15 华东医院 A kind of excretion body protein is as identifying the good pernicious marker of Lung neoplasm and its application
CN113711313A (en) * 2019-02-15 2021-11-26 佰欧迪塞克斯公司 Predictive test for identifying early-stage NSCLC patients at high risk of relapse after surgery
CN110473167B (en) * 2019-07-09 2022-06-17 哈尔滨工程大学 Deep learning-based urinary sediment image recognition system and method
CN112892619B (en) * 2019-12-04 2022-07-15 香港城市大学深圳研究院 PDMS (polydimethylsiloxane) master mold with arc-shaped edge section, micro-fluidic valve and chip and preparation thereof
KR102613772B1 (en) * 2021-02-02 2023-12-14 제노마인(주) Method and Kit for Detecting Blood Biomarkers of Lung Cancer

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000052204A2 (en) * 1999-02-22 2000-09-08 Orntoft Torben F Gene expression in bladder tumors
US6596503B1 (en) * 2000-08-18 2003-07-22 East Carolina University Monoclonal antibody DS6, tumor-associated antigen CA6, and methods of use thereof
WO2006016697A1 (en) * 2004-08-10 2006-02-16 Oncotherapy Science, Inc. Non-small cell lung cancer-related gene, anln, and its interactions with rhoa
EP2298895A1 (en) * 2005-07-27 2011-03-23 Oncotherapy Science, Inc. Method of diagnosing small cell lung cancer
US20080305962A1 (en) 2005-07-29 2008-12-11 Ralph Markus Wirtz Methods and Kits for the Prediction of Therapeutic Success, Recurrence Free and Overall Survival in Cancer Therapies
US8445198B2 (en) * 2005-12-01 2013-05-21 Medical Prognosis Institute Methods, kits and devices for identifying biomarkers of treatment response and use thereof to predict treatment efficacy
US8014957B2 (en) * 2005-12-15 2011-09-06 Fred Hutchinson Cancer Research Center Genes associated with progression and response in chronic myeloid leukemia and uses thereof
WO2008046911A2 (en) * 2006-10-20 2008-04-24 Exiqon A/S Novel human micrornas associated with cancer
GB0803192D0 (en) * 2008-02-22 2008-04-02 Mubio Products Bv SCLC biomarker panel
US10359425B2 (en) * 2008-09-09 2019-07-23 Somalogic, Inc. Lung cancer biomarkers and uses thereof
ES2559758T3 (en) * 2008-09-09 2016-02-15 Somalogic, Inc. Biomarkers of lung cancer and their uses
CA2743473C (en) 2008-11-17 2022-06-14 Veracyte, Inc. Methods and compositions of molecular profiling for disease diagnostics
US20110236903A1 (en) * 2008-12-04 2011-09-29 Mcclelland Michael Materials and methods for determining diagnosis and prognosis of prostate cancer
US9624547B2 (en) * 2010-02-10 2017-04-18 The Regents Of The University Of California Salivary transcriptomic and proteomic biomarkers for breast cancer detection
AU2011223789A1 (en) 2010-03-01 2012-09-20 Caris Life Sciences Switzerland Holdings Gmbh Biomarkers for theranostics
CA2795776A1 (en) 2010-04-06 2011-10-13 Caris Life Sciences Luxembourg Holdings, S.A.R.L. Circulating biomarkers for disease

Also Published As

Publication number Publication date
JP2015501154A (en) 2015-01-15
KR20140082840A (en) 2014-07-02
EP2771692A4 (en) 2015-08-26
CN106168624A (en) 2016-11-30
EP2771692B1 (en) 2018-04-18
JP5986638B2 (en) 2016-09-06
SG11201400375SA (en) 2014-04-28
WO2013062515A2 (en) 2013-05-02
CA3064363A1 (en) 2013-05-02
MX355416B (en) 2018-04-18
BR112014006432B8 (en) 2022-10-25
CA2847188C (en) 2020-02-18
AU2011378427B2 (en) 2015-07-16
IL231426A0 (en) 2014-04-30
CN103890586A (en) 2014-06-25
MX2014004860A (en) 2014-05-27
CA2847188A1 (en) 2013-05-02
BR112014006432A2 (en) 2017-04-04
NZ621733A (en) 2015-05-29
CA3006793A1 (en) 2013-05-02
KR101921945B1 (en) 2018-11-26
ES2674318T3 (en) 2018-06-28
CN106168624B (en) 2018-03-13
ZA201401476B (en) 2016-06-29
IL252163A0 (en) 2017-07-31
EP2771692A2 (en) 2014-09-03
AU2011378427A8 (en) 2015-08-27
AU2011378427A1 (en) 2013-05-16
CA3006793C (en) 2020-02-18
CN103890586B (en) 2016-06-29
IL231426A (en) 2017-06-29
BR112014006432B1 (en) 2021-04-06
WO2013062515A3 (en) 2014-04-17
AU2011378427B8 (en) 2015-08-27
CA3064363C (en) 2022-05-17

Similar Documents

Publication Publication Date Title
IN2014CN01787A (en)
MX341517B (en) Pancreatic cancer biomarkers and uses thereof.
EP3029153A3 (en) Mesothelioma biomarkers and uses thereof
MX355020B (en) Lung cancer biomarkers and uses thereof.
MX2020004617A (en) Cardiovascular risk event prediction and uses thereof.
GB2478441A (en) Lung cancer biomarkers and uses thereof
EP2566983A4 (en) Serial analysis of biomarkers for disease diagnosis
WO2012177945A3 (en) Diagnostic methods for eosinophilic esophagitis
WO2014160275A3 (en) Biomarkers for liver fibrosis
BR112012019542A2 (en) "method for assessing renal status in an individual, measuring one or more biomarkers, and, kit"
EA030186B9 (en) Method for performing quantitation assays
NZ605698A (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure
WO2014186761A3 (en) Methods for determining responsiveness to an anti-cd47 agent
WO2008128043A3 (en) Diagnostic and prognostic methods for renal cell carcinoma
EA201500080A1 (en) METHOD IN VITRO DIAGNOSIS AND MONITORING OF CANCER
WO2015095862A3 (en) Microrna biomarkers for ovarian cancer
GB201014837D0 (en) Biomarker signatures and uses thereof
EP3135774A3 (en) Complex sets of mirnas as non-invasive biomarkers for kidney cancer
WO2011137388A3 (en) Identification and use of biomarkers for detection and quantification of the level of radiation exposure in a biological sample
WO2015189591A3 (en) Method and arrays for use in diagnosing early breast cancer
WO2012139052A3 (en) Antibody biomarkers for diabetes
NZ601648A (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure
EP3557259A3 (en) Methods and arrays for use in the same
WO2012135620A3 (en) Molecular gram stain
WO2014160237A3 (en) Methods of prognosing preeclampsia